Trial intelligence / Profile preview

Pilot trial of dabigatran as alternative anticoagulant in patients with left ventricular assist device

2010-024534-38Phase 2Terminated

Sponsor
Medical University of Vienna
Start
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of dabigatran in heart failure (HF) and Mechanical Circulatory Support (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Major and minor thromboembolic adverse events. Started Jun 2011; status: terminated.

02

Drugs

dabigatran
03

Conditions

heart failure (HF)Mechanical Circulatory Support

Beyond the preview

Go deeper on 2010-024534-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024534-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call